STANDEX REPORTS FISCAL FOURTH QUARTER AND FISCAL YEAR 2024 FINANCIAL RESULTS
Standex International (NYSE: SXI) reported financial results for Q4 FY2024. Key highlights include:
- Q4 sales declined 4.3% to $180.2M, with acquisitions and fast growth markets partially offsetting organic decline
- Q4 adjusted operating margin of 16.0%, up 60 bps sequentially and YOY
- FY2024 record profit and cash generation:
- Adjusted gross margin of 39.4%, up 90 bps YOY
- Adjusted operating margin of 15.8%, up 60 bps YOY
- Free cash flow of $73M
For FY2025, Standex plans to release over a dozen new products, expecting to contribute over 100 bps of growth. Fast growth market sales are projected to grow >20% and exceed $110M. The company anticipates improved market conditions leading to a healthier growth backdrop in 2H FY2025.
Standex International (NYSE: SXI) ha riportato i risultati finanziari per il Q4 FY2024. Le principali evidenze includono:
- Le vendite del Q4 sono diminuite del 4,3% a 180,2 milioni di dollari, con acquisizioni e mercati in rapida crescita che hanno parzialmente compensato il calo organico.
- Il margine operativo rettificato del Q4 è stato del 16,0%, in aumento di 60 punti base rispetto al trimestre precedente e rispetto all'anno precedente.
- Record di profitto e generazione di cassa per l'FY2024:
- Margine lordo rettificato del 39,4%, in aumento di 90 punti base anno su anno.
- Margine operativo rettificato del 15,8%, in aumento di 60 punti base anno su anno.
- Flusso di cassa libero di 73 milioni di dollari.
Per l'FY2025, Standex prevede di lanciare oltre una dozzina di nuovi prodotti, aspettandosi di contribuire con oltre 100 punti base di crescita. Le vendite nei mercati in rapida crescita sono previste in aumento di oltre il 20% e supereranno i 110 milioni di dollari. L'azienda prevede miglioramenti nelle condizioni di mercato che porteranno a un contesto di crescita più sano nel secondo semestre dell'FY2025.
Standex International (NYSE: SXI) informó sobre los resultados financieros del cuarto trimestre del año fiscal 2024. Los puntos destacados incluyen:
- Las ventas del cuarto trimestre cayeron un 4,3% a 180,2 millones de dólares, con adquisiciones y mercados de rápido crecimiento que compensaron parcialmente la disminución orgánica.
- El margen operativo ajustado del cuarto trimestre fue del 16,0%, aumentando 60 puntos básicos secuencialmente y en comparación con el año anterior.
- Récord de beneficios y generación de efectivo para el año fiscal 2024:
- Margen bruto ajustado del 39,4%, un aumento de 90 puntos básicos en comparación con el año anterior.
- Margen operativo ajustado del 15,8%, un aumento de 60 puntos básicos en comparación con el año anterior.
- Flujo de caja libre de 73 millones de dólares.
Para el año fiscal 2025, Standex planea lanzar más de una docena de nuevos productos, esperando contribuir con más de 100 puntos básicos de crecimiento. Se proyecta que las ventas en mercados de rápido crecimiento aumenten más del 20% y superen los 110 millones de dólares. La compañía anticipa una mejora en las condiciones del mercado que llevará a un escenario de crecimiento más saludable en la segunda mitad del año fiscal 2025.
스탠덱스 인터내셔널 (NYSE: SXI)는 2024 회계연도 4분기 재무 결과를 발표했습니다. 주요 하이라이트는 다음과 같습니다:
- 4분기 매출이 4.3% 감소하여 1억 8020만 달러에 도달했으며, 인수와 빠른 성장 시장이 유기적 감소를 부분적으로 상쇄했습니다.
- 4분기 조정 후 운영 마진은 16.0%로, 이전 분기 및 전년 대비 60bp 증가했습니다.
- 2024 회계연도 기록적 이익 및 현금 생성:
- 조정 후 총 마진은 39.4%로, 전년 대비 90bp 증가했습니다.
- 조정 후 운영 마진은 15.8%로, 전년 대비 60bp 증가했습니다.
- 자유 현금 흐름은 7300만 달러입니다.
2025 회계연도에 대해 스탠덱스는 10개 이상의 신제품을 출시할 계획이며, 100bp 이상의 성장에 기여할 것으로 예상하고 있습니다. 빠른 성장 시장의 매출은 20% 이상 성장하여 1억 1000만 달러를 초과할 것으로 보입니다. 회사는 2025 회계연도 하반기에 더 건강한 성장 환경으로 이어질 시장 상황 개선을 예상하고 있습니다.
Standex International (NYSE: SXI) a publié ses résultats financiers pour le 4ème trimestre de l'exercice fiscal 2024. Les points saillants incluent :
- Les ventes du 4ème trimestre ont diminué de 4,3% pour atteindre 180,2 millions de dollars, avec des acquisitions et des marchés à forte croissance compensant partiellement le déclin organique.
- La marge opérationnelle ajustée du 4ème trimestre s'est élevée à 16,0%, en hausse de 60 points de base par rapport au trimestre précédent et par rapport à l'année précédente.
- Bénéfices records et génération de trésorerie pour l'exercice 2024 :
- Marge brute ajustée de 39,4%, en hausse de 90 points de base par rapport à l'année précédente.
- Marge opérationnelle ajustée de 15,8%, en hausse de 60 points de base par rapport à l'année précédente.
- Flux de trésorerie libre de 73 millions de dollars.
Pour l'exercice 2025, Standex prévoit de lancer plus d'une douzaine de nouveaux produits, s'attendant à contribuer à plus de 100 points de base de croissance. Les ventes dans les marchés à forte croissance devraient augmenter de plus de 20% et dépasser 110 millions de dollars. L'entreprise anticipe des conditions de marché améliorées qui devraient entraîner un contexte de croissance plus sain dans la seconde moitié de l'exercice 2025.
Standex International (NYSE: SXI) hat die finanziellen Ergebnisse für das 4. Quartal des Geschäftsjahres 2024 veröffentlicht. Die wichtigsten Highlights sind:
- Der Umsatz im 4. Quartal sank um 4,3% auf 180,2 Millionen USD, wobei Akquisitionen und schnell wachsende Märkte den organischen Rückgang teilweise ausglichen.
- Die bereinigte operative Marge im 4. Quartal lag bei 16,0%, was einer Steigerung von 60 Basispunkten gegenüber dem Vorquartal und zum Vorjahr entspricht.
- Rekordgewinne und Cash-Generierung für das Geschäftsjahr 2024:
- Bereinigte Bruttomarge von 39,4%, ein Anstieg um 90 Basispunkte im Vergleich zum Vorjahr.
- Bereinigte operative Marge von 15,8%, ein Anstieg um 60 Basispunkte im Vergleich zum Vorjahr.
- Freier Cashflow von 73 Millionen USD.
Für das Geschäftsjahr 2025 plant Standex die Einführung von über einem Dutzend neuer Produkte und erwartet, dass dies über 100 Basispunkte des Wachstums beitragen wird. Der Umsatz in den schnell wachsenden Märkten wird auf einen Anstieg von mehr als 20% geschätzt und soll 110 Millionen USD übertreffen. Das Unternehmen erwartet eine Verbesserung der Marktbedingungen, die zu einem gesünderen Wachstumsumfeld in der zweiten Hälfte des Geschäftsjahres 2025 führen wird.
- Q4 adjusted operating margin improved 60 bps YOY to 16.0%
- FY2024 achieved record profit and cash generation
- FY2024 adjusted gross margin increased 90 bps YOY to 39.4%
- FY2024 adjusted operating margin rose 60 bps YOY to 15.8%
- Free cash flow generation of $73 million in FY2024
- Fast growth market sales increased 13% YOY to $27 million in Q4
- Plan to release over a dozen new products in FY2025, expected to contribute over 100 bps of growth
- Fast growth market sales projected to grow >20% and exceed $110 million in FY2025
- Q4 sales declined 4.3% YOY to $180.2 million
- Q4 GAAP operating income decreased 4.7% YOY to $27.1 million
- Q4 free cash flow decreased 32.3% YOY to $22.2 million
- Engraving segment revenue decreased 22.8% YOY in Q4
- Scientific segment revenue declined 4.1% YOY in Q4
- Specialty Solutions revenue decreased 6.3% YOY in Q4
Insights
Standex International's Q4 FY24 results present a mixed picture with some positive developments amid challenging market conditions. The 4.3% year-over-year sales decline was partially offset by contributions from acquisitions and growth in fast-growth markets. Notably, the company achieved an adjusted operating margin of 16.0%, up 60 basis points both sequentially and year-over-year, demonstrating effective cost management and operational efficiency.
The company's focus on fast-growth markets is paying off, with sales in these areas increasing by
Financially, Standex remains robust with a strong balance sheet and impressive cash generation. The free cash flow of $22.2 million in Q4, representing
Looking ahead, Standex's outlook for FY25 is cautiously optimistic. The planned release of over a dozen new products across all business segments is expected to contribute over 100 basis points of growth. Moreover, the projected
However, investors should note the segment-specific challenges, particularly in the Engraving segment, which saw a significant
Standex's Q4 results reflect broader market trends and offer insights into several key industries. The company's performance in fast-growth markets, particularly the
The softness in appliances and general industrial end markets in China and Europe indicates ongoing challenges in these regions, possibly due to economic uncertainties and shifting consumer behaviors. This trend may persist in the short term, affecting companies with significant exposure to these markets.
The normalization in the Display Merchandising business within the Specialty Solutions segment suggests a potential cooling in retail-related investments, which could be a broader indicator for the retail sector. Conversely, the growth in the Hydraulics business points to strength in industries relying on this technology, such as construction and material handling.
Standex's emphasis on new product development, with plans to release over a dozen new products in FY25, reflects a broader industry trend of innovation-driven growth. This strategy is particularly important in a competitive landscape where product differentiation can be a key driver of market share.
The company's expectation of stabilizing general market conditions in the first half of FY25 and strengthening in the second half aligns with broader economic forecasts. This outlook suggests a cautious optimism for industrial and manufacturing sectors in the coming year, which could be valuable for investors considering exposure to these areas.
- In Q4 FY24, Sales Declined
4.3% with Contributions from Acquisitions and Fast Growth Markets Partially Offsetting Organic Decline; Fast Growth Market Sales Increased ~13% YOY to$27 Million - Q4 FY24 GAAP Operating Margin of
15.1% ; Adjusted Operating Margin of16.0% , Up 60 bps Sequentially and YOY - Record Profit and Cash Generation in FY24:
- GAAP Gross Margin of
39.1% ; Adjusted Gross Margin of39.4% , up 90 bps YOY - GAAP Operating Margin of
14.1% ; Adjusted Operating Margin of15.8% , up 60 bps YOY - Free Cash Flow Generation of
$73 Million
- GAAP Gross Margin of
- Continued Investments to Support Growth; R&D Spend Increased
to$3.3 Million 2.8% of Sales in FY24 - In FY25, Plan to Release Over a Dozen New Products, At Least One in Every Business, Contributing Over 100 bps of Growth; Fast Growth Market Sales Expected to Grow >
20% and Exceed$110 million - Continued Improvement in General Market Conditions Expected to Lead to Healthier Backdrop for Growth in 2H FY25
Summary Financial Results - Total | |||||
($M except EPS and Dividends) | 4Q24 | 4Q23 | 3Q24 | Y/Y | Q/Q |
Net Sales | -4.3 % | 1.7 % | |||
Operating Income – GAAP | -4.7 % | 24.3 % | |||
Operating Income – Adjusted | -1.0 % | 5.1 % | |||
Operating Margin % - GAAP | 15.1 % | 15.1 % | 12.3 % | 0 bps | + 280 bps |
Operating Margin % - Adjusted | 16.0 % | 15.4 % | 15.4 % | + 60 bps | + 60 bps |
Net Income from Continuing Ops – GAAP | -2.5 % | 23.5 % | |||
Net Income from Continuing Ops – Adjusted | -1.3 % | 1.0 % | |||
EBITDA | -4.9 % | 19.3 % | |||
EBITDA margin | 18.8 % | 18.9 % | 16.0 % | - 10 bps | + 280 bps |
Adjusted EBITDA | -2.0 % | 2.9 % | |||
Adjusted EBITDA margin | 19.7 % | 19.2 % | 19.5 % | + 50 bps | + 20 bps |
Diluted EPS – GAAP | -1.2 % | 23.0 % | |||
Diluted EPS – Adjusted | 0.0 % | 0.6 % | |||
Dividends per Share | 7.1 % | 0.0 % | |||
Free Cash Flow | -32.3 % | 15.3 % | |||
Net Debt to EBITDA | 0.0x | -0.2x | 0.0x | NM | NM |
Fourth Quarter Fiscal 2024 Results
Commenting on the quarter's results, President and Chief Executive Officer David Dunbar said, "We concluded our fiscal year with yet another solid operational performance in the fourth quarter, which demonstrates the resilient character of our employees to adapt and execute on initiatives under our control, despite continued softness in general market conditions. Sales from fast growth markets such as electric vehicles, renewable energy, smart grid, and the commercialization of space increased
"Following record profitability in fiscal year 2023, we delivered new records in fiscal year 2024 in adjusted gross margin, adjusted operating income, adjusted operating margin, adjusted earnings per share, and free cash flow. We remain optimistic about our long-term operating margin potential as we leverage better general market conditions and a higher sales contribution from new products and new applications."
"We remain confident about the secular trends in our fast growth end markets. In fiscal year 2024, our fast growth market sales grew
"We are beginning fiscal year 2025 in a strong position for continued improvements in financial performance. Our balance sheet remains in a strong position to consider an active funnel of organic and inorganic opportunities."
Outlook
In the fiscal first quarter 2025, on a sequential basis, the Company expects similar to slightly higher revenue, as higher sales into fast growth markets are mostly offset by less favorable project timing in the Engineering Technologies segment. The Company expects sequentially similar to slightly higher gross margin and slightly lower to similar adjusted operating margin due to higher investments in selling, marketing, and R&D.
In fiscal year 2025, the Company expects general market conditions to stabilize in the first half and strengthen in the second half. The Company plans to release over a dozen new products, at least one in every business, which it expects will contribute over 100 bps of incremental growth. Sales from fast growth markets are expected to grow above
Fourth Quarter Segment Operating Performance
Electronics (45% of sales;
4Q24 | 4Q23 | % Change | |
Electronics ($M) | |||
Revenue | 80.4 | 79.9 | 0.6 % |
GAAP Operating Income | 16.1 | 16.8 | -4.0 % |
GAAP Operating Margin % | 20.1 | 21.0 | |
Adjusted Operating Income* | 16.5 | 16.8 | -2.2 % |
Adjusted Operating Margin %* | 20.5 | 21.0 |
* Excludes purchase accounting expenses of |
Revenue increased approximately
Electronics segment backlog realizable in under one year of approximately
In fiscal first quarter 2025, on a sequential basis, the Company expects similar to slightly higher revenue, driven by higher sales into fast growth end markets, and similar adjusted operating margin, as higher investments in selling, marketing, and R&D offset pricing and productivity initiatives.
Engraving (
4Q24 | 4Q23 | % Change | |
Engraving ($M) | |||
Revenue | 32.7 | 42.4 | -22.8 % |
Operating Income | 3.9 | 7.9 | -50.0 % |
Operating Margin % | 12.0 | 18.6 |
Revenue decreased approximately
In fiscal first quarter 2025, on a sequential basis, the Company expects moderately higher revenue and operating margin due to more favorable project timing in
Scientific (
4Q24 | 4Q23 | % Change | |
Scientific ($M) | |||
Revenue | 17.5 | 18.3 | -4.1 % |
Operating Income | 4.9 | 4.7 | 5.7 % |
Operating Margin % | 28.1 | 25.5 |
Revenue decreased approximately
In fiscal first quarter 2025, on a sequential basis, the Company expects similar revenue and slightly lower operating margin due to R&D investments and higher freight cost.
Engineering Technologies (
4Q24 | 4Q23 | % Change | |
Engineering Technologies ($M) | |||
Revenue | 25.3 | 21.8 | 15.7 % |
Operating Income | 5.3 | 3.1 | 70.4 % |
Operating Margin % | 20.9 | 14.2 |
Revenue increased approximately
In fiscal first quarter 2025, on a sequential basis, the Company expects moderately to significantly lower revenue and slightly lower operating margin due to unfavorable project timing.
Specialty Solutions (
4Q24 | 4Q23 | % Change | |
Specialty Solutions ($M) | |||
Revenue | 24.2 | 25.9 | -6.3 % |
Operating Income | 5.4 | 6.4 | -16.2 % |
Operating Margin % | 22.2 | 24.8 |
Specialty Solutions revenue decreased approximately
In fiscal first quarter 2025, on a sequential basis, the Company expects similar revenue and operating margin.
Capital Allocation
- Share Repurchase: During the fiscal fourth quarter 2024, the Company did not repurchase shares. There was
$33.3 million remaining on the Company's current share repurchase authorization at the end of the fiscal fourth quarter 2024. - Capital Expenditures: In fiscal fourth quarter 2024, Standex's capital expenditures were
compared to$6.5 million in the fiscal fourth quarter of 2023. The Company now expects fiscal year 2025 capital expenditures between$7.6 million and$35 million . Capital expenditures were$40 million in fiscal 2024.$20.3 million - Dividend: On July 26, 2024, the Company declared a quarterly cash dividend of
per share, an approximately$0.30 7.1% year-on-year increase. The dividend is payable August 23, 2024, to shareholders of record on August 9, 2024.
Balance Sheet and Cash Flow Highlights
- Net Debt: Standex had net (cash) debt of
( on June 30, 2024, compared to$5.3) million ( at the end of fiscal fourth quarter 2023. Net debt for the fourth quarter of 2024 consisted primarily of long-term debt of$22.3) million and cash and equivalents of$148.9 million .$154.2 million - Cash Flow: Net cash provided by continuing operating activities for the three months ended June 30, 2024, was
$28.7 million compared to million in the prior year's quarter. Free cash flow after capital expenditures was$40.4 $22.2 million compared to free cash flow after capital expenditures of$32.8 million in the fiscal fourth quarter of 2023.
Conference Call Details
Standex will host a conference call for investors tomorrow, August 2, 2024, at 8:30 a.m. ET. On the call, David Dunbar, President, and CEO, and Ademir Sarcevic, CFO, will review the Company's financial results and business and operating highlights. Investors interested in listening to the webcast and viewing the slide presentation should log on to the "Investors" section of Standex's website under the subheading, "Events and Presentations," located at www.standex.com.
A replay of the webcast will also be available on the Company's website shortly after the conclusion of the presentation online through August 2, 2025. To listen to the teleconference playback, please dial in the
Use of Non-GAAP Financial Measures
In addition to the financial measures prepared in accordance with generally accepted accounting principles ("GAAP"), the Company uses certain non-GAAP financial measures, including non-GAAP adjusted income from operations, non-GAAP adjusted net income from continuing operations, free operating cash flow, EBITDA (earnings before interest, taxes, depreciation and amortization) adjusted EBITDA, adjusted EBITDA to net debt, and adjusted earnings per share. The attached financial tables reconcile non-GAAP measures used in this press release to the most directly comparable GAAP measures. The Company believes that the use of non-GAAP measures which include the impact of restructuring charges, purchase accounting, insurance recoveries, discrete tax events, gain or loss on sale of a business unit, acquisition costs, and litigation costs help investors to obtain a better understanding of our operating results and prospects, consistent with how management measures and forecasts the Company's performance, especially when comparing such results to previous periods. An understanding of the impact in a particular quarter of specific restructuring costs, acquisition expenses, or other gains and losses, on net income (absolute as well as on a per-share basis), operating income or EBITDA can give management and investors additional insight into core financial performance, especially when compared to quarters in which such items had a greater or lesser effect, or no effect. Non-GAAP measures should be considered in addition to, and not as a replacement for, the corresponding GAAP measures, and may not be comparable to similarly titled measures reported by other companies.
About Standex
Standex International Corporation is a multi-industry manufacturer in five broad business segments: Electronics, Engraving, Scientific, Engineering Technologies, and Specialty Solutions with operations in
Forward-Looking Statements
Statements contained in this Press Release that are not based on historical facts are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of forward-looking terminology such as "should," "could," "may," "will," "expect," "believe," "estimate," "anticipate," "intend," "continue," or similar terms or variations of those terms or the negative of those terms. There are many factors that affect the Company's business and the results of its operations and that may cause the actual results of operations in future periods to differ materially from those currently expected or anticipated. These factors include, but are not limited to: the impact of pandemics and other global crises or catastrophic events on employees, our supply chain, and the demand for our products and services around the world; materially adverse or unanticipated legal judgments, fines, penalties or settlements; conditions in the financial and banking markets, including fluctuations in exchange rates and the inability to repatriate foreign cash; domestic and international economic conditions, including the impact, length and degree of economic downturns on the customers and markets we serve and more specifically conditions in the automotive, construction, aerospace, defense, transportation, food service equipment, consumer appliance, energy, oil and gas and general industrial markets; lower-cost competition; the relative mix of products which impact margins and operating efficiencies in certain of our businesses; the impact of higher raw material and component costs, particularly steel, certain materials used in electronics parts, petroleum based products, and refrigeration components; the impact of higher transportation and logistics costs, especially with respect to transportation of goods from
Standex International Corporation | ||||||||||||
Consolidated Statement of Operations | ||||||||||||
(unaudited) | ||||||||||||
Three Months Ended | Year Ended | |||||||||||
June 30, | June 30, | |||||||||||
(In thousands, except per share data) | 2024 | 2023 | 2024 | 2023 | ||||||||
Net sales | $ | 180,194 | 188,327 | $ | 720,635 | $ | 741,048 | |||||
Cost of sales | 110,781 | 114,701 | 438,634 | 455,952 | ||||||||
Gross profit | 69,413 | 73,626 | 282,001 | 285,096 | ||||||||
Selling, general and administrative expenses | 40,974 | 44,579 | 169,599 | 172,335 | ||||||||
(Gain) loss on sale of business | - | - | (274) | (62,105) | ||||||||
Restructuring costs | 903 | 501 | 8,206 | 3,831 | ||||||||
Acquisition related costs | 389 | 70 | 2,622 | 557 | ||||||||
Other operating (income) expense, net | - | - | 110 | (611) | ||||||||
Income from operations | 27,147 | 28,476 | 101,738 | 171,089 | ||||||||
Interest expense | 1,300 | 1,237 | 4,544 | 5,405 | ||||||||
Other non-operating (income) expense, net | 266 | 40 | 2,071 | 1,735 | ||||||||
Total | 1,566 | 1,277 | 6,615 | 7,140 | ||||||||
Income from continuing operations before income taxes | 25,581 | 27,199 | 95,123 | 163,949 | ||||||||
Provision for income taxes | 5,893 | 7,013 | 21,532 | 24,796 | ||||||||
Net income from continuing operations | 19,688 | 20,186 | 73,591 | 139,153 | ||||||||
Income (loss) from discontinued operations, net of tax | (97) | (17) | (517) | (161) | ||||||||
Net income | $ | 19,591 | $ | 20,169 | $ | 73,074 | $ | 138,992 | ||||
Basic earnings per share: | ||||||||||||
Income (loss) from continuing operations | $ | 1.67 | $ | 1.71 | $ | 6.26 | $ | 11.78 | ||||
Income (loss) from discontinued operations | - | - | (0.04) | (0.01) | ||||||||
Total | $ | 1.67 | $ | 1.71 | $ | 6.22 | $ | 11.77 | ||||
Diluted earnings per share: | ||||||||||||
Income (loss) from continuing operations | $ | 1.66 | $ | 1.68 | $ | 6.18 | $ | 11.59 | ||||
Income (loss) from discontinued operations | (0.01) | - | (0.04) | (0.01) | ||||||||
Total | $ | 1.65 | $ | 1.68 | $ | 6.14 | $ | 11.58 | ||||
Average Shares Outstanding | ||||||||||||
Basic | 11,761 | 11,767 | 11,763 | 11,810 | ||||||||
Diluted | 11,892 | 12,009 | 11,904 | 12,009 |
Standex International Corporation | ||||||
Condensed Consolidated Balance Sheets | ||||||
(unaudited) | ||||||
June 30, | June 30, | |||||
(In thousands) | 2024 | 2023 | ||||
ASSETS | ||||||
Current assets: | ||||||
Cash and cash equivalents | $ | 154,203 | 195,706 | |||
Accounts receivable, net | 121,365 | 123,440 | ||||
Inventories | 87,106 | 98,537 | ||||
Prepaid expenses and other current assets | 67,421 | 65,570 | ||||
Total current assets | 430,095 | 483,253 | ||||
Property, plant, equipment, net | 134,963 | 130,937 | ||||
Intangible assets, net | 78,673 | 75,651 | ||||
Goodwill | 281,283 | 264,821 | ||||
Deferred tax asset | 17,450 | 14,602 | ||||
Operating lease right-of-use asset | 37,078 | 33,273 | ||||
Other non-current assets | 25,515 | 22,392 | ||||
Total non-current assets | 574,962 | 541,676 | ||||
Total assets | $ | 1,005,057 | $ | 1,024,929 | ||
LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||
Current liabilities: | ||||||
Accounts payable | $ | 63,364 | 68,601 | |||
Accrued liabilities | 56,698 | 62,031 | ||||
Income taxes payable | 7,503 | 10,335 | ||||
Total current liabilities | 127,565 | 140,967 | ||||
Long-term debt | 148,876 | 173,441 | ||||
Operating lease long-term liabilities | 30,725 | 25,774 | ||||
Accrued pension and other non-current liabilities | 76,388 | 77,298 | ||||
Total non-current liabilities | 255,989 | 276,513 | ||||
Stockholders' equity: | ||||||
Common stock | 41,976 | 41,976 | ||||
Additional paid-in capital | 106,193 | 100,555 | ||||
Retained earnings | 1,086,277 | 1,027,279 | ||||
Accumulated other comprehensive loss | (182,956) | (158,477) | ||||
Treasury shares | (429,987) | (403,884) | ||||
Total stockholders' equity | 621,503 | 607,449 | ||||
Total liabilities and stockholders' equity | $ | 1,005,057 | $ | 1,024,929 |
Standex International Corporation and Subsidiaries | ||||||
Statements of Consolidated Cash Flows | ||||||
(unaudited) | ||||||
Year Ended | ||||||
June 30, | ||||||
(In thousands) | 2024 | 2023 | ||||
Cash Flows from Operating Activities | ||||||
Net income | $ | 73,074 | 138,992 | |||
Income (loss) from discontinued operations | (517) | (161) | ||||
Income from continuing operations | 73,591 | 139,153 | ||||
Adjustments to reconcile net income to net cash provided by operating activities: | ||||||
Depreciation and amortization | 28,140 | 28,474 | ||||
Stock-based compensation | 9,811 | 11,710 | ||||
Non-cash portion of restructuring charge | 151 | (444) | ||||
(Gain) loss on sale of business | (274) | (62,105) | ||||
Contributions to defined benefit plans | (10,238) | (451) | ||||
Net changes in operating assets and liabilities | (7,835) | (25,569) | ||||
Net cash provided by operating activities - continuing operations | 93,346 | 90,768 | ||||
Net cash provided by (used in) operating activities - discontinued operations | (690) | 33 | ||||
Net cash provided by (used in) operating activities | 92,656 | 90,801 | ||||
Cash Flows from Investing Activities | ||||||
Expenditures for property, plant and equipment | (20,298) | (24,270) | ||||
Expenditures for acquisitions, net of cash acquired | (48,835) | - | ||||
Proceeds from the sale of business | 7,774 | 67,023 | ||||
Other investing activities | (270) | (1,190) | ||||
Net cash provided by (used in) investing activities | (61,629) | 41,563 | ||||
Cash Flows from Financing Activities | ||||||
Proceeds from borrowings | - | 224,500 | ||||
Payments of debt | (25,000) | (226,200) | ||||
Contingent consideration payment | - | (1,167) | ||||
Activity under share-based payment plans | 1,525 | 1,341 | ||||
Purchase of treasury stock | (31,824) | (25,527) | ||||
Cash dividends paid | (13,902) | (12,985) | ||||
Net cash provided by (used in) financing activities | (69,201) | (40,038) | ||||
Effect of exchange rate changes on cash | (3,329) | (1,464) | ||||
Net changes in cash and cash equivalents | (41,503) | 90,862 | ||||
Cash and cash equivalents at beginning of year | 195,706 | 104,844 | ||||
Cash and cash equivalents at end of period | $ | 154,203 | $ | 195,706 |
Standex International Corporation | ||||||||||||
Selected Segment Data | ||||||||||||
(unaudited) | ||||||||||||
Three Months Ended | Year Ended | |||||||||||
June 30, | June 30, | |||||||||||
(In thousands) | 2024 | 2023 | 2024 | 2023 | ||||||||
Net Sales | ||||||||||||
Electronics | $ | 80,417 | $ | 79,906 | $ | 321,956 | $ | 305,872 | ||||
Engraving | 32,749 | 42,445 | 150,685 | 152,067 | ||||||||
Scientific | 17,521 | 18,278 | 68,931 | 74,924 | ||||||||
Engineering Technologies | 25,271 | 21,835 | 83,476 | 81,079 | ||||||||
Specialty Solutions | 24,236 | 25,863 | 95,587 | 127,106 | ||||||||
Total | $ | 180,194 | $ | 188,327 | $ | 720,635 | $ | 741,048 | ||||
Income from operations | ||||||||||||
Electronics | $ | 16,146 | $ | 16,819 | $ | 64,030 | $ | 68,979 | ||||
Engraving | 3,943 | 7,882 | 26,708 | 25,462 | ||||||||
Scientific | 4,926 | 4,660 | 19,000 | 17,109 | ||||||||
Engineering Technologies | 5,270 | 3,093 | 15,216 | 11,050 | ||||||||
Specialty Solutions | 5,381 | 6,424 | 19,631 | 25,368 | ||||||||
Restructuring | (903) | (501) | (8,206) | (3,831) | ||||||||
Gain (loss) on sale of business | - | - | 274 | 62,105 | ||||||||
Acquisition related costs | (389) | (70) | (2,622) | (557) | ||||||||
Corporate | (7,227) | (9,831) | (32,183) | (35,207) | ||||||||
Other operating income (expense), net | - | - | (110) | 611 | ||||||||
Total | $ | 27,147 | $ | 28,476 | $ | 101,738 | $ | 171,089 |
Standex International Corporation | |||||||||||||||||
Reconciliation of GAAP to Non-GAAP Financial Measures | |||||||||||||||||
(unaudited) | |||||||||||||||||
Three Months Ended | Year Ended | ||||||||||||||||
June 30, | June 30, | ||||||||||||||||
(In thousands, except percentages) | 2024 | 2023 | % Change | 2024 | 2023 | % Change | |||||||||||
Adjusted income from operations and adjusted net income from continuing operations: | |||||||||||||||||
Net Sales | $ | 180,194 | $ | 188,327 | -4.3 % | $ | 720,635 | $ | 741,048 | -2.8 % | |||||||
Income from operations, as reported | $ | 27,147 | $ | 28,476 | -4.7 % | $ | 101,738 | $ | 171,089 | -40.5 % | |||||||
Income from operations margin | 15.1 % | 15.1 % | 14.1 % | 23.1 % | |||||||||||||
Adjustments: | |||||||||||||||||
Restructuring charges | 903 | 501 | 8,206 | 3,831 | |||||||||||||
Acquisition-related costs | 389 | 70 | 2,622 | 557 | |||||||||||||
Litigation (settlement refund) charge | - | - | - | (882) | |||||||||||||
(Gain) loss on sale of business | - | - | (274) | (62,105) | |||||||||||||
Environmental remediation | - | - | 110 | 271 | |||||||||||||
Property insurance deductible | - | - | - | - | |||||||||||||
Purchase accounting expenses | 305 | - | 1,768 | - | |||||||||||||
Adjusted income from operations | $ | 28,744 | $ | 29,047 | -1.0 % | $ | 114,170 | $ | 112,761 | 1.2 % | |||||||
Adjusted income from operations margin | 16.0 % | 15.4 % | 15.8 % | 15.2 % | |||||||||||||
Interest and other income (expense), net | (1,566) | (1,277) | (6,615) | (7,140) | |||||||||||||
Foreign currency related (gain) loss on acquisition and divestiture activities | - | - | 309 | - | |||||||||||||
Life insurance benefit | - | - | - | - | |||||||||||||
Provision for income taxes | (5,893) | (7,013) | (21,532) | (24,796) | |||||||||||||
Discrete and other tax items | - | - | 100 | 100 | |||||||||||||
Tax impact of above adjustments | (396) | 416 | (2,964) | (353) | |||||||||||||
Net income from continuing operations, as adjusted | $ | 20,889 | $ | 21,173 | -1.3 % | $ | 83,468 | $ | 80,572 | 3.6 % | |||||||
EBITDA and Adjusted EBITDA: | |||||||||||||||||
Net income (loss) from continuing operations, as reported | $ | 19,688 | $ | 20,186 | -2.5 % | $ | 73,591 | $ | 139,153 | ||||||||
Net income from continuing operations margin | 10.9 % | 10.7 % | 10.2 % | 18.8 % | |||||||||||||
Add back: | |||||||||||||||||
Provision for income taxes | 5,893 | 7,013 | 21,532 | 24,796 | |||||||||||||
Interest expense | 1,300 | 1,237 | 4,544 | 5,405 | |||||||||||||
Depreciation and amortization | 6,994 | 7,200 | 28,140 | 28,474 | |||||||||||||
EBITDA | $ | 33,875 | $ | 35,636 | -4.9 % | $ | 127,807 | $ | 197,828 | -35.4 % | |||||||
EBITDA Margin | 18.8 % | 18.9 % | 17.7 % | 26.7 % | |||||||||||||
Adjustments: | |||||||||||||||||
Restructuring charges | 903 | 501 | 8,206 | 3,831 | |||||||||||||
Acquisition-related costs | 389 | 70 | 2,622 | 557 | |||||||||||||
Litigation (settlement refund) charge | - | - | - | (882) | |||||||||||||
(Gain) loss on sale of business | - | - | (274) | (62,105) | |||||||||||||
Foreign currency related (gain) loss on acquisition and divestiture activities | - | - | 309 | - | |||||||||||||
Environmental remediation | - | - | 110 | 271 | |||||||||||||
Life insurance benefit | - | - | - | - | |||||||||||||
Purchase accounting expenses | 305 | - | 1,768 | - | |||||||||||||
Adjusted EBITDA | $ | 35,472 | $ | 36,207 | -2.0 % | $ | 140,548 | $ | 139,500 | 0.8 % | |||||||
Adjusted EBITDA Margin | 19.7 % | 19.2 % | 19.5 % | 18.8 % | |||||||||||||
Free operating cash flow: | |||||||||||||||||
Net cash provided by operating activities - continuing operations, as reported | $ | 28,737 | $ | 40,413 | $ | 93,346 | $ | 90,768 | |||||||||
Add back: Voluntary pension contribution | - | - | - | - | |||||||||||||
Less: Capital expenditures | (6,533) | (7,622) | (20,298) | (24,270) | |||||||||||||
Free cash flow from continuing operations | $ | 22,204 | $ | 32,791 | $ | 73,048 | $ | 66,498 |
Standex International Corporation | |||||||||||||||||
Reconciliation of GAAP to Non-GAAP Financial Measures | |||||||||||||||||
(unaudited) | |||||||||||||||||
Three Months Ended | Year Ended | ||||||||||||||||
Adjusted earnings per share from continuing operations | June 30, | June 30, | |||||||||||||||
2024 | 2023 | % | 2024 | 2023 | % Change | ||||||||||||
Diluted earnings per share from continuing operations, as reported | $ | 1.66 | $ | 1.68 | -1.2 % | $ | 6.18 | $ | 11.59 | -46.7 % | |||||||
Adjustments: | |||||||||||||||||
Restructuring charges | 0.06 | 0.03 | 0.53 | 0.24 | |||||||||||||
Acquisition-related costs | 0.02 | - | 0.17 | 0.03 | |||||||||||||
Litigation (settlement refund) charge | - | - | - | (0.06) | |||||||||||||
(Gain) loss on sale of business | - | 0.05 | (0.02) | (5.13) | |||||||||||||
Foreign currency related (gain) loss on acquisition and divestiture activities | - | - | 0.02 | ||||||||||||||
Environmental remediation | - | - | 0.01 | 0.02 | |||||||||||||
Discrete tax items | - | - | 0.01 | 0.01 | |||||||||||||
Purchase accounting expenses | 0.02 | - | 0.11 | - | |||||||||||||
Diluted earnings per share from continuing operations, as adjusted | $ | 1.76 | $ | 1.76 | 0.0 % | $ | 7.01 | $ | 6.70 | 4.6 % |
View original content to download multimedia:https://www.prnewswire.com/news-releases/standex-reports-fiscal-fourth-quarter-and-fiscal-year-2024-financial-results-302212831.html
SOURCE Standex International Corporation
FAQ
What was Standex's (SXI) Q4 FY2024 revenue?
How did Standex's (SXI) adjusted operating margin perform in Q4 FY2024?
What was Standex's (SXI) free cash flow in FY2024?
How much did Standex's (SXI) fast growth market sales increase in Q4 FY2024?